Therefore, we conducted this study to evaluate the incidence of CDK9 overexpression in Middle Eastern epithelial ovarian cancer (EOC) patient specimens and explore its predictive as well as prognostic value in this patient cohort. The gene discussed is CDK9; the disease is ovarian carcinoma.